The global idiopathic thrombocytopenic purpura therapeutics market is projected to experience substantial growth, with a Compound Annual Growth Rate (CAGR) of 5.4% during the period 2022 to 2032. According to recent market analysis, the market, valued at USD 642 million in 2022, is expected to surge to USD 1,086.28 million by 2032. The escalating demand …